Researchers used dual-energy X-ray absorptiometry (DEXA) scans to measure precise changes in fat mass and lean mass across 189 participants with type 2 diabetes over 36 weeks
Safety profile data for each ingredient indicates good tolerability when used within recommended dosage ranges, though individual sensitivities and potential drug interactions require consideration
For WorldatWork Members Total Rewards Inventory of Programs & Practices, research 5 Health Benefits Trends Come into Focus for 2024, Workspan Magazine article Navigating Employees Serious Medical Needs, on-demand webinar Total Rewards Inventory Checklist, tool For Everyone Employer Healthcare Costs Projected to Hit 10-Year High in 2025, Workspan Daily article Employers Look to Balance Rising Health Costs, Benefit Upgrades in 2025, Workspan Daily article As Health Costs Spike, Total Rewards and CFO Collaboration Is Crucial, Workspan Daily article Employers Grapple with the Rising Costs and Popularity of Specialty Weight-Loss Drugs, Workspan Daily article With the glucagon-like peptide-1 (or GLP-1) class of drugs now approved by the U.S
CPT1A, carnitine palmitoyltransferase 1A